Analyst Research Report Snapshot

Title:

Vivus, Inc.

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

06 Jul 2015

Pages:

44

Type:

AcrobatPDF

Companies referenced:

VVUS.OQ

Available for Immediate Download
Summary:

Vivus, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Vivus, Inc. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Vivus, Inc. in the form of a SWOT analysis - An in-depth view of the business model of Vivus, Inc. including a breakdown and examination of key business segments - Intelligence on Vivus, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Vivus, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Vivus (or 'the company') is a biopharmaceutical company focused on research, development and commercialization of products in the areas of sexual health, obesity and diabetes. The company primarily operates in the US. Vivus is headquartered in Mountain View, California, and employed 98 people as of February 19, 2014. The company recorded revenues of $81.1 million during the financial year ended December 2013 (FY2013), as compared to revenues of $2 million in FY2012. The operating loss of the company was $154.6 million in FY2013, as compared to an operating loss of $139.9 million in FY2012. The net loss was $174.5 million in FY2013, as compared to a net loss of $139.9 million in FY2012. Reasons to Purchase: - Gain understanding of Vivus, Inc. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Vivus, Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Vivus, Inc.’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.